TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Pulse Biosciences ( (PLSE) ) just unveiled an announcement.
On November 13, 2025, Pulse Biosciences, Inc. released an updated investor presentation on its website, highlighting recent advancements in its product development programs. This presentation is intended for use in discussions with investors and analysts, showcasing the company’s progress with its nPulse technology products, which could influence its market positioning and stakeholder interests.
The most recent analyst rating on (PLSE) stock is a Buy with a $22.00 price target. To see the full list of analyst forecasts on Pulse Biosciences stock, see the PLSE Stock Forecast page.
Spark’s Take on PLSE Stock
According to Spark, TipRanks’ AI Analyst, PLSE is a Neutral.
Pulse Biosciences receives a low overall score due to persistent financial challenges such as continuous losses and cash burn. While technical indicators show some positive momentum, the valuation remains unattractive due to negative earnings. The earnings call provided a balanced view with notable advancements in technology and strengthened finances, but increased operational costs remain a concern. The CFO appointment is a positive strategic move but does not significantly affect the overall score.
To see Spark’s full report on PLSE stock, click here.
More about Pulse Biosciences
Pulse Biosciences, Inc. operates in the medical technology industry, focusing on the development of innovative bioelectric medicine solutions. The company is known for its proprietary nPulse technology, which includes products like the nPulse Vybrance Percutaneous Electrode, nPulse Cardiac Clamp, and nPulse Cardiac Catheter, aimed at advancing medical treatments.
Average Trading Volume: 178,151
Technical Sentiment Signal: Hold
Current Market Cap: $1.02B
See more data about PLSE stock on TipRanks’ Stock Analysis page.